Capital Research Global Investors trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,966,490 shares of the healthcare conglomerate’s stock after selling 15,806 shares during the period. UnitedHealth Group comprises about 1.9% of Capital Research Global Investors’ holdings, making the stock its 7th biggest holding. Capital Research Global Investors owned 1.95% of UnitedHealth Group worth $9,088,540,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on UNH. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Erste Group Bank upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Wednesday. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Twenty-one equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $632.85.
UnitedHealth Group Stock Down 22.0 %
Shares of UNH stock opened at $456.10 on Friday. The stock has a market cap of $417.20 billion, a P/E ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a fifty day moving average price of $512.95 and a 200 day moving average price of $540.65. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the company earned $6.91 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.84%. UnitedHealth Group’s payout ratio is presently 54.19%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Dividend Payout Ratio Calculator
- AppLovin: Can Record Profits Overcome Market Skepticism?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 04/14 – 04/18
- How to Find Undervalued Stocks
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.